Ryvyl, NeoGenomics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

-0.57% Pre

+5.55% Pre

+0.85% Pre

+0.25% Pre

-3.23% Pre

agilon health inc

AGL

0.99

-0.57%

0.00% Pre

Ambiq Micro, Inc.

AMBQ

35.19

+5.55%

0.00% Pre

CryoPort, Inc.

CYRX

10.65

+0.85%

0.00% Pre

Apollo Strategic Growth Capital Class A

GBTG

8.17

+0.25%

0.00% Pre

MiNK Therapeutics, Inc.

INKT

12.00

-3.23%

0.00% Pre

U.S. stock futures were mostly flat this morning, with the Dow futures gaining around 0.01% on Tuesday.

Shares of Ryvyl Inc (NASDAQ:RVYL) fell sharply in pre-market trading after the company announced a 1-for-35 reverse stock split to regain Nasdaq $1 minimum bid compliance.

Ryvyl shares tumbled 14.4% to $0.13 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Mink Therapeutics Inc (NASDAQ:INKT) dipped 13.4% to $10.50 in pre-market trading.
SMX (Security Matters) PLC (NASDAQ:SMX) shares dipped 8.2% to $78.00 in pre-market trading after declining 27% on Monday.
NeoGenomics, Inc. (NASDAQ:NEO) declined 7.1% to $11.43 in pre-market trading. NeoGenomics named diagnostics and lab services industry veteran John P. “Jack” Kenny to its Board of Directors.
CryoPort Inc (NASDAQ:CYRX) tumbled 5% to $9.10 in pre-market trading.
agilon health, inc. (NYSE:AGL) slipped 4.3% to $0.7060 in pre-market trading.
Global Business Travel Group, Inc. (NASDAQ:GBTG) fell 3.1% to $7.45 in pre-market trading.
Ambiq Micro, Inc. (NYSE:AMBQ) slipped 2.6% to $28.40 in pre-market trading.
Yum China Holdings, Inc. (NYSE:YUMC) fell 2.1% to $47.50 in pre-market trading.

Now Read This:

How To Earn $500 A Month From Apogee Enterprises Stock (APOG) Ahead Of Q3 Earnings

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.